 Ginkgo Bioworks, Inc. and Soaring Eagle Acquisition Corp., a special purpose acquisition company, have announced their 17B merger transaction will finalize in Q321 resulting in Ginkgo earning a 15B EV. Ginkgo Bioworks is a high-growth analytical biotechnology company applying automation for contract-based cell engineering utilizing a combination of computational and synthetic biological practices. 